Zimmer Biomet Holdings Inc  

(Public, NYSE:ZBH)   Watch this stock  
Find more results for NYSE:ZMH
+0.58 (0.47%)
May 27 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 122.06 - 123.43
52 week 88.27 - 123.43
Open 122.34
Vol / Avg. 1.02M/1.31M
Mkt cap 24.63B
P/E 494.65
Div/yield 0.24/0.78
EPS 0.25
Shares 199.24M
Beta 0.95
Inst. own 94%
Jul 28, 2016
Q2 2016 Zimmer Biomet Holdings Inc Earnings Release (Estimated) - 7:30AM EDT - Add to calendar
May 11, 2016
Zimmer Biomet Holdings Inc at Bank of America Merrill Lynch Health Care Conference
May 5, 2016
Zimmer Biomet Holdings Inc at Deutsche Bank Health Care Conference
May 4, 2016
Zimmer Holdings Inc Annual Shareholders Meeting (Estimated)
May 3, 2016
Zimmer Biomet Holdings Inc Annual Shareholders Meeting
Apr 28, 2016
Q1 2016 Zimmer Biomet Holdings Inc Earnings Call - Webcast
Apr 28, 2016
Q1 2016 Zimmer Biomet Holdings Inc Earnings Release
Mar 16, 2016
Zimmer Biomet Holdings Inc at Barclays Global Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 5.56% 2.44%
Operating margin 12.89% 7.79%
EBITD margin - 33.54%
Return on average assets 1.59% 0.79%
Return on average equity 4.35% 1.79%
Employees 17,500 -
CDP Score - 62 E


345 E Main St
WARSAW, IN 46580-2746
United States - Map
+1-574-2676131 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Zimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.

Officers and directors

David C. Dvorak President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Daniel P. Florin Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Stuart G. Kleopfer President, Americas
Age: 53
Bio & Compensation  - Reuters
Katarzyna Mazur-Hofsaess M.D. Ph.D. President, Europe, Middle East and Africa
Age: 52
Bio & Compensation  - Reuters
Sang Yi President, Asia Pacific
Age: 54
Bio & Compensation  - Reuters
Chad F. Phipps Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tony W. Collins Chief Accounting Officer, Vice President, Corporate Controller
Age: 47
Bio & Compensation  - Reuters
Adam Rudolph Johnson Group President, Spine, Dental, CMF and Thoracic
Age: 38
Bio & Compensation  - Reuters
David A. Nolan Jr. Group President of Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle and Bone Healing
Age: 50
Bio & Compensation  - Reuters
Daniel E. Williamson Group President, Joint Reconstruction
Age: 50
Bio & Compensation  - Reuters